A detailed history of First Hawaiian Bank transactions in Astrazeneca PLC stock. As of the latest transaction made, First Hawaiian Bank holds 14,015 shares of AZN stock, worth $915,880. This represents 0.04% of its overall portfolio holdings.

Number of Shares
14,015
Previous 14,723 4.81%
Holding current value
$915,880
Previous $1.15 Million 4.88%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$76.67 - $87.62 $54,282 - $62,034
-708 Reduced 4.81%
14,015 $1.09 Million
Q2 2024

Jul 02, 2024

BUY
$66.81 - $80.83 $65,741 - $79,536
984 Added 7.16%
14,723 $1.15 Million
Q1 2024

Apr 05, 2024

SELL
$61.03 - $69.57 $52,119 - $59,412
-854 Reduced 5.85%
13,739 $930,000
Q4 2023

Jan 08, 2024

SELL
$61.89 - $69.28 $22,218 - $24,871
-359 Reduced 2.4%
14,593 $982,000
Q3 2023

Oct 10, 2023

BUY
$64.85 - $71.7 $8,041 - $8,890
124 Added 0.84%
14,952 $1.01 Million
Q2 2023

Jul 06, 2023

BUY
$69.91 - $75.81 $7,829 - $8,490
112 Added 0.76%
14,828 $1.06 Million
Q1 2023

Apr 18, 2023

BUY
$63.15 - $71.6 $20,208 - $22,912
320 Added 2.22%
14,716 $1.02 Million
Q4 2022

Jan 12, 2023

SELL
$54.21 - $70.44 $22,768 - $29,584
-420 Reduced 2.83%
14,396 $977,000
Q3 2022

Oct 05, 2022

BUY
$53.02 - $135.75 $31,387 - $80,364
592 Added 4.16%
14,816 $813,000
Q2 2022

Jul 22, 2022

BUY
$59.26 - $71.14 $64,889 - $77,898
1,095 Added 8.34%
14,224 $940,000
Q1 2022

Apr 06, 2022

BUY
$55.72 - $67.12 $203,489 - $245,122
3,652 Added 38.54%
13,129 $870,000
Q4 2021

Jan 12, 2022

BUY
$54.02 - $63.83 $511,947 - $604,916
9,477 New
9,477 $552,000
Q2 2019

Jul 15, 2019

SELL
$37.28 - $41.68 $57,224 - $63,978
-1,535 Closed
0 $0
Q3 2018

Oct 16, 2018

BUY
$34.76 - $39.72 $53,356 - $60,970
1,535 New
1,535 $60,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track First Hawaiian Bank Portfolio

Follow First Hawaiian Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.